Polymorphisms in the IκB-α promoter region and risk of diseases involving inflammation and fibrosis

Genes and Immunity

Volumn 2, Issue 3, 2001, Pages 153-155

  Mozzato Chamay, N ^a   Corbett, E L ^a   Bailey, R L ^a,b   Mabey, D C W ^a   Raynes, J ^a   Conway, D J ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

Fibrosis; I B (IkappaB alpha gene); Promoter; Silicosis; Single nucleotide polymorphism (SNP); Trachoma

Indexed keywords

DNA BINDING PROTEIN; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA;

ARTICLE; GAMBIA; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; HUMAN; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROMOTER REGION; SILICOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH AFRICA; TRACHOMA;

BASE SEQUENCE; DNA-BINDING PROTEINS; GAMBIA; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; I-KAPPA B PROTEINS; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); SILICOSIS; SOUTH AFRICA; TRACHOMA;

EID: 0035348059     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363753     Document Type: Article

References (11)

1. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16: 225-260.
2. Brown K, Park S, Kanno T, Franzoso G, Siebenlist U. Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha. Proc Natl Acad Sci USA 1993; 90: 2532-2536.
3. Tojima Y, Fujimoto A, Delhase M et al. NAK is an I Kappa B kinase-activating kinase. Nature 2000; 404: 778-782.
4. Emmerich F, Meiser M, Hummel M et al. Overexpression of IκB-α without inhibition of NFκB activity and mutations in the IκB-α gene in Reed-Steinberg cells. Blood 1999; 94: 3129-3134.
5. Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR. A simplified system for the assessment of trachoma and its complications. Bull WHO 1987; 65: 477-483.
6. Wagner GR. Asbestos and silicosis. Lancet 1997; 349: 1311-1315.
7. Ito CY, Kazantsev AG, Baldwin AS Jr. Three NFκB sites in the IκB-alpha promoter are required for induction of gene expression by TNF-alpha. Nucl Acids Res 1994; 22: 3787-3792.
8. Le Bail O, Schmidt-Ullrich R, Israel A. Promoter analysis of the gene encoding the IκB-α/MAD3 inhibitor of NFκB: positive regulation by members of the rel/NFκB family. EMBO J 1993; 12: 5043-5049.
9. Mozzato-Chamay N, Mahdi OSM, Jallow O, Mabey DCW, Bailey RL, Conway DJ. Polymorphisms in candidate genes and risk of scarring trachoma in a Chlamydia trachomatis-endemic population. J Infect Dis 2000; 182: 1545-1548.
10. Corbett E, Mozzato-Chamay N, Butterworth AE et al. Polymorphisms in the tumor necrosis factor-α gene promoter may predispose to severe silicosis in black South African miners. Submitted for publication.
11. Conway DJ, Holland MJ, Bailey RL et al. Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-α) gene promoter and with elevated TNF-α levels in tear fluid. Infect Immun 1997; 65: 1000-1006.